The ongoing Bundibugyo virus outbreak in the Democratic Republic of the Congo, declared in mid-May 2026 and now the fastest-growing and second-largest Ebola event on record, dominates trader views for countries recording at least one case this year. Rapid spread across seven provinces amid conflict, displacement, and weak surveillance has produced thousands of confirmed infections and deaths, with imported cases already logged in Uganda and France. Limited local transmission outside the DRC epicenter, successful containment in Uganda after its 42-day monitoring period, and no further community spread reported elsewhere keep the market focused on these three nations while highlighting risks of additional exports before year-end. Precursor signals such as contact-tracing gaps and population mobility suggest potential for further movement, though response efforts including early vaccination campaigns could limit new countries.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jourWhich countries will have an Ebola case in 2026?
$38,814 Vol.
South Sudan
46%
Rwanda
25%
Burundi
38%
United States
18%
Canada
35%
Kenya
23%
India
45%
Republic of the Congo
22%
Nigeria
50%
Ethiopia
53%
Somalia
35%
China
12%
$38,814 Vol.
South Sudan
46%
Rwanda
25%
Burundi
38%
United States
18%
Canada
35%
Kenya
23%
India
45%
Republic of the Congo
22%
Nigeria
50%
Ethiopia
53%
Somalia
35%
China
12%
Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Marché ouvert : May 22, 2026, 12:35 PM ET
Résolveur
0x65070BE91...Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.
The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Résolveur
0x65070BE91...The ongoing Bundibugyo virus outbreak in the Democratic Republic of the Congo, declared in mid-May 2026 and now the fastest-growing and second-largest Ebola event on record, dominates trader views for countries recording at least one case this year. Rapid spread across seven provinces amid conflict, displacement, and weak surveillance has produced thousands of confirmed infections and deaths, with imported cases already logged in Uganda and France. Limited local transmission outside the DRC epicenter, successful containment in Uganda after its 42-day monitoring period, and no further community spread reported elsewhere keep the market focused on these three nations while highlighting risks of additional exports before year-end. Precursor signals such as contact-tracing gaps and population mobility suggest potential for further movement, though response efforts including early vaccination campaigns could limit new countries.
Résumé expérimental généré par IA à partir des données Polymarket. Ceci n'est pas un conseil de trading et ne joue aucun rôle dans la résolution de ce marché. · Mis à jour


Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes